Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis

Return to Table of Contents

HIV-TB Drug Interaction Guideline Development Group

• Chair: Kelly Dooley, MD, PhD, Johns Hopkins University, Baltimore MD USA
• Co-chair: William Burman, MD, Denver Public Health, Denver CO, USA
• Co-chair: Andrew Vernon, MD, MHS, Centers for Disease Control and Prevention, Atlanta GA, USA

Guideline Development Group members:

• Debra Benator, MD, Washington DC Veterans Admin. Medical Center, Washington, DC, USA
• Constance Benson, MD, University of San Diego, San Diego, CA, USA
• David Burger, Pharm D, PhD, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands
• Mark Cotton, MD PhD, Stellenbosch University, Tygerberg, South Africa
• Jonathan Kaplan, MD, Centers for Disease Control and Prevention, Atlanta, GA, USA
• Gary Maartens, MD, University of Cape Town, Cape Town, South Africa
• Helen McIlleron, MBChB, PhD, University of Cape Town, Cape Town, South Africa
• Jose M. Miro, MD, PhD, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
• Lynne Mofenson, MD, NICHD, AIDS Branch, National Institutes of Health, Bethesda, MD, USA
• Alice Pau, Pharm D, NIAID, National Institutes of Health, Bethesda, MD, USA
• Paul Pham, Pharm D, Johns Hopkins University, Baltimore, MD, USA
• Charles Peloquin, Pharm D, University of Florida, Gainesville, FL, USA
• George Siberry, MD, NICHD, AIDS Branch, National Institutes of Health, Bethesda, MD, USA
• Timothy Sterling, MD, Vanderbilt University, Nashville, TN, USA
• Kimberly Struble, Pharm D, Center for Drug Evaluation & Research, Food and Drug Administration, Rockville MD, USA
• Montserrat Tuset, Pharm D, PhD, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain
• Heather Watts, MD, NICHD, AIDS Branch, National Institutes of Health, Bethesda, MD, USA
• Paul Weidle, Pharm D, MPH, Centers for Disease Control and Prevention, Atlanta, GA, USA
• Marc Weiner, MD, Audie L. Murphy Veterans Admin. Medical Center, San Antonio TX, USA

Competing Interests

Members of the writing group were asked if they served as employees, if they served on a paid advisory board, if they owned stock, if they received grants, or if they received speaker fees from companies whose products were reviewed. The following competing interests were reported:

N=No competing interest

Y=Yes, possible competing interest as noted